NR 507 Week 3 Assignment; Alterations in Pulmonary Function.
Document Preview
Unlock Full 22 Page Document Instantly.
Document Overview
Measure Definition Maneuver Forced Vital The FVC measures the Pa琀椀ent inhales as deep as possible and then Capacity (FVC); volume of air in the lungs exhales as long and as forcefully as possible. Normal 80-120% that can be exhaled. Forced Expiratory Amount of air forcefully The pa琀椀ent inhales and forcefully exhales as Volume in 1 exhaled from the lungs in the fast as possible. second (FEV1); 昀椀rst second. Normal 80- 120% Determines if the pa琀琀ern is This is a calculated ra琀椀o that represents the FEV1/FVC ra琀椀o obstruc琀椀ve, restric琀椀ve or propor琀椀on of a person's vital capacity that they normal are able to expire in the 昀椀rst second of forced expira琀椀on to the full, forced vital capacity. Di昀昀using capacity: The di昀昀using capacity is simply how well the lungs are able to exchange gas. Gas exchange is most e昀케cient in a lung that has high surface area because it’s easier for the blood to pick up the gas that’s being exchange. An example of a condi琀椀on that decreases the pa琀椀ent’s di昀昀using capacity because of a loss of surface area is emphysema. Condi琀椀ons that increase the lungs thickness can also decrease di昀昀using capacity as in the case of pulmonary 昀椀brosis. Residual volume (RV) and Total Lung Capacity (TLC): RV is the amount of air that remains in the lungs a昀琀er a forceful exhala琀椀on. RV + FVC = TLC. Note that the RV cannot be measured by spirometry. Other methods are used that require the pa琀椀ent to inhale an inert gas (helium) or sit in an air琀椀ght booth where the pressure is measured during breathing. These measurements are also called sta琀椀c lung volumes. The values add to the informa琀椀on obtained from spirometry. If the pa琀椀ent has an obstruc琀椀ve disease, RV and TLC results will be elevated which reveals air trapping and hyperin昀氀a琀椀on. In restric琀椀ve disease, the TLC is needed to con昀椀rm true restric琀椀on. It can also help in quan琀椀fying the degree of restric琀椀on. Steps to Analyze Pulmonary Func琀椀on Tests (PFTs) First, the NP must understand how the results of the PFT is delivered. The results will yield measured values and percentages of predicted values. Predicted values and lower limits of normal have been standardized by popula琀椀on studies using individuals without lung disease. Each pa琀椀ent’s predicted values depend on the age, height, and gender. This informa琀椀on is entered into a computer prior to the PFT. Once the results have been received, the NP looks at two factors: 1) the pa琀琀ern of the condi琀椀on; 2) severity of the condi琀椀on. Step 1: Determine the Pa琀琀ern In order to classify the respiratory issue as either obstruc琀椀ve, restric琀椀ve or normal., the NP starts by looking at the FEV1/FVC ra琀椀o. Obstruc琀椀ve pa琀琀ern: If the FEV1/FVC ra琀椀o is less than 70% or less than the lower limit of normal for the pa琀椀ent. FEV1 also falls to a greater degree than the FVC. Restric琀椀ve pa琀琀ern: If the FEV1/FVC ra琀椀o is greater than 70% or greater than the lower limit of normal, then the spirometry test is either normal, or a restric琀椀ve respiratory abnormality
Full content available after purchase or with an active subscription.
Related Products
Related Products
NR 507 Week 1 Assignment; Immune Response
NR 507 Week 1 Discussion; Allergies and Immunocompromised States
NR 507 Week 1 Discussion; Human Immunodeficiency Virus (HIV)
NR 507 Week 1 Discussion; Immune System Dysfunction & Rash Analysis
NR 507 Week 1 Discussion; Immunity; Hypersensitivity-Immunodeficiency
NR 507 Week 1 Discussion; Introductions (not graded, but required)
NR 507 Week 1 Discussion; Introductions (not graded, but required) & Summary
NR 507 Week 1 Discussion; Pathophysiology and Clinical Aspects of HIV
NR 507 Week 1 Edapt Practice Questions; Hypersensitivity, anemias, immunodeficiency.
NR 507 Week 1 Edapt; Anemias & hemoglobinopathies
NR 507 Week 1 Edapt; Hypersensitivity
NR 507 Week 1 Edapt; Introduction to Anemia
NR 507 Week 1-3 Edapt; Questions and Materials
NR 507 Week 2 Assignment; Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological and Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological Disorders
NR 507 Week 2 Clinical Reasoning Webinar Transcript
NR 507 Week 2 Discussion; Amyotrophic Lateral Sclerosis (ALS)
NR 507 Week 2 Discussion; Choose Your Own Pathophysiology Adventure, Part 1 of 3
NR 507 Week 2 Discussion; Chronic Obstructive Pulmonary Disease
NR 507 Week 2 Edapt Practice Questions; Cardiovascular and Hematology Disorders
NR 507 Week 2 Edapt; Cardio & Hematologic Components; Key Points & Final Review
NR 507 Week 2 Edapt; Cardiovascular and hematology disorders - Practice Questions-Answers
NR 507 Week 2 Edapt; Cardiovascular Disorders
NR 507 Week 2 Edapt; Hematology
NR 507 Week 2 Edapt; Study Guide Anemia
NR 507 Week 3 Assignment; Alterations in Pulmonary Function
NR 507 Week 3 Discussion
NR 507 Week 3 Discussion; Anemia and Its Implications
NR 507 Week 3 Discussion; Heart failure (HF)
NR 507 Week 3 Discussion; Pathophysiology of Anemia and Asthma
NR 507 Week 3 Edapt Practice Questions; Respiratory System
NR 507 Week 3 Edapt; Obstructive and Restrictive Lung Diseases
NR 507 Week 3 Edapt; Respiratory System - Practice Questions-Answers
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders.
NR 507 Week 4 Collaboration Cafe; Cardiovascular Involvement in SLE Pathophysiology
NR 507 Week 4 Collaboration Cafe; Urinary System Pathologies
NR 507 Week 4 Edapt Practice Questions; Urinary, Renal System
NR 507 Week 4 Edapt; Urinary System Pathologies
NR 507 Week 4 Midterm Exam Practice Questions-Answers
NR 507 Week 4 Midterm Exam Solved
NR 507 Week 4 Midterm Exam..
NR 507 Week 4 Midterm Practice Exam Questions (Weeks 1-4)
NR 507 Week 4 Midterm Real Past Exam Questions-Answers
NR 507 Week 4-5 Edapt Questions and Material
NR 507 Week 5 Assignment; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3 - Sickle Cell Disease
NR 507 Week 5 Discussion; COPD and Its Implications
NR 507 Week 5 Edapt; Anxiety Disorders
NR 507 Week 5 Edapt; Depression
NR 507 Week 5 Edapt; GERD; Alterations in the Gastrointestinal System
NR 507 Week 5 Edapt; Inflammatory Bowel Disease
NR 507 Week 5 Edapt; Liver Cirrhosis
NR 507 Week 5 Edapt; Mood Disorders
NR 507 Week 5 Edapt; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Edapt; Peptic Ulcer Disease
NR 507 Week 5 Edapt; Schizophrenia, Ch 19, Pg 618
NR 507 Week 5-6 Edapt Content
NR 507 Week 6 Assignment; Alterations in the Endocrine System
NR 507 Week 6 Case Study; Pathophysiology & Clinical Findings of Type 2 Diabetes
NR 507 Week 6 Discussion
NR 507 Week 6 Discussion; Cirrhosis
NR 507 Week 7 Assignment; CNS; Sensory and Motor Disorders
NR 507 Week 7 CNS; Sensory and Motor Disorders
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3 - Heart Failure and Neuropathy
NR 507 Week 7 Edapt Content; CNS Sensory and Motor Disorders
NR 507 Week 8 CNS; Brain Disorders & Dermatological Conditions
NR 507 Week 8 Collaboration Cafe
NR 507 Week 8 Collaborative Cafe
NR 507 Week 8 Edapt Content; CNS Brain Disorders
NR 507 Week 8 Final Exam - Questions-Answers
NR 507 Week 8 Final Exam Compilation
NR 507 Week 8 Final Exam Master Study Guide
NR 507 Week 8 Final Exam Master Study Guide - Answered Bullet-by-Bullet.
NR 507 Week 8 Final Exam Review - Made this for the final and really helped me ace it!
NR 507 Week 8 Final Exam Study Guide Review
NR 507 Week 8 Final Exam..
NR 507 Week 8 Group Final Exam Questions
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.